Complaint

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sunnova Energy International Inc. of Class Action Lawsuit and Upcoming Deadlines – NOVA

Retrieved on: 
Monday, April 8, 2024
Electricity, NOVA, Letter, House Committee, Risk, District court, State, The Washington Free Beacon, Natural Resources, News, Ext, LLP, Complaint, Commerce, Energy, Pomerantz, Sunnova, Action Replay, DOE, Court, Person

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sunnova Energy International Inc. (“Sunnova” or the “Company”) (NYSE: NOVA) and certain officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sunnova Energy International Inc. (“Sunnova” or the “Company”) (NYSE: NOVA) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lantronix, Inc. of Class Action Lawsuit and Upcoming Deadlines – LTRX

Retrieved on: 
Monday, April 8, 2024
Intelligence, EPS, Internet of things, District court, Internet, Ext, LLP, Transport, Complaint, City, Person, Pomerantz, Action Replay, Court, IOT

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Lantronix, Inc. (“Lantronix” or the “Company”) (NASDAQ: LTRX) and certain officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Lantronix, Inc. (“Lantronix” or the “Company”) (NASDAQ: LTRX) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTYX

Retrieved on: 
Monday, April 8, 2024
Prior, Psoriasis, Register, Form, District court, Defendant, News, Ext, LLP, IPO, Security (finance), Inflammation, Plaque, Prospectus, Complaint, File, Pomerantz, Action Replay, Court, Person

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX) and certain officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Ventyx is a clinical-stage biopharmaceutical company that develops small-molecule product candidates to address a range of inflammatory diseases.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amylyx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – AMLX

Retrieved on: 
Monday, April 8, 2024
Prior, Apoptosis, ALS, District court, Patient, AMX0035, Amyotrophy, Ext, LLP, Prescription, IBD, Complaint, Pomerantz, Action Replay, Food, Court, Evercore, Person, Pharmaceutical industry

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Amylyx Pharmaceuticals, Inc.  (“Amylyx” or the “Company”) (NASDAQ: AMLX) and certain officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Amylyx Pharmaceuticals, Inc.  (“Amylyx” or the “Company”) (NASDAQ: AMLX) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

DEADLINE ALERT for INMD, AMPL, and NOVA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Monday, April 8, 2024
Law, Acceleration, Risk, COVID-19, Defendant, Suite, Complaint, Investment, Amplitude, Sunnova, FDA, Security (finance)

LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • The Law Offices of Frank R. Cruz, Los Angeles

DEADLINE TODAY: The Schall Law Firm Encourages Investors in New York Community Bancorp, Inc. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Monday, April 8, 2024
New York Community Bank, Certification, Ethics, NYCB, Complaint, Suite, Security (finance)

Investors who purchased the Company’s securities between March 1, 2023 and February 5, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before April 8, 2024.

Key Points: 
  • Investors who purchased the Company’s securities between March 1, 2023 and February 5, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before April 8, 2024.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Hut 8 Corp. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Monday, April 8, 2024
Bitcoin, Certification, Ethics, Data mining, Complaint, Suite, Hut 8, Security (finance)

Investors who purchased the Company’s securities between November 9, 2023 and January 18, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before April 8, 2024.

Key Points: 
  • Investors who purchased the Company’s securities between November 9, 2023 and January 18, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before April 8, 2024.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Snowflake, Chemours, and Evolv and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, April 8, 2024
Annual report, Ethics, CFO, Weapon, Risk, School, Air conditioning, Electronics, Snowflake Inc., News, Controller, Refrigeration, Form 10-K, IPO, Transport, Senior, SNOW, Complaint, Adjustment, P.C, Plastic, Audit committee, Cryptocurrency

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • which lowered credit consumption.”  On this news, the price of Snowflake Class A common stock fell nearly 28% over several trading sessions, damaging investors.
  • After the market closed on February 9, 2023, Chemours announced its fourth quarter and full year 2022 financial results.
  • For more information on the Evolv class action go to: https://bespc.com/cases/EVLV

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against InMode, Innodata, Fox Factory, and X and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, April 8, 2024
Research, Class Action, Growth, Palo Alto Networks, Federation, Defendant, Food and Drug Administration, Dermatology, News, AI, Nature, Silicon, Complaint, P.C, Goldengate, Research and development, Fox Factory, Confidentiality, Injury, Wolfpack, Marketing, Dentist, FDA

InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.

Key Points: 
  • InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies.
  • Specifically, Defendants repeatedly touted the demand for InMode’s devices and told investors that those devices were never sold at a discount.
  • The complaint further alleges that when these misleading statements and omissions about Fox Factory’s business reached the market, investors were harmed significantly.
  • For more information on the Palo Alto Networks class action go to: https://bespc.com/cases/PANW

INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - INMD

Retrieved on: 
Monday, April 8, 2024
SAN, Food and Drug Administration, News, Complaint, Pension fund, Food, FDA, Tobacco

), the InMode class action lawsuit charges InMode as well as certain of InMode’s top executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • ), the InMode class action lawsuit charges InMode as well as certain of InMode’s top executives with violations of the Securities Exchange Act of 1934.
  • Lead plaintiff motions for the InMode class action lawsuit must be filed with the court no later than April 15, 2024.
  • A lead plaintiff acts on behalf of all other class members in directing the InMode class action lawsuit.
  • An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the InMode class action lawsuit.